Skip to main content

15-05-2018 | Rheumatoid arthritis | Article

Cardiovascular (CV) risk after initiation of abatacept versus TNF inhibitors in rheumatoid arthritis patients with and without baseline CV disease

Jin Y et al. J Rheumatol 2018. doi: 10.3899/jrheum.170926

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics